These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26958802)

  • 81. Drug treatment: explaining the gender paradox.
    Fiorentine R; Anglin MD; Gil-Rivas V; Taylor E
    Subst Use Misuse; 1997 May; 32(6):653-78. PubMed ID: 9178435
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Substance use in individuals with mental retardation.
    McGillicuddy NB; Blane HT
    Addict Behav; 1999; 24(6):869-78. PubMed ID: 10628519
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Oral Healthcare for Persons With Intellectual or Developmental Disabilities: Why Is There a Disparity?
    Milano M
    Compend Contin Educ Dent; 2017; 38(10):e5-e8. PubMed ID: 29140099
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Health disparities between women with and without disabilities: a review of the research.
    Wisdom JP; McGee MG; Horner-Johnson W; Michael YL; Adams E; Berlin M
    Soc Work Public Health; 2010 May; 25(3):368-86. PubMed ID: 20446182
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Barriers to accessing substance abuse treatment in Mexico: national comparative analysis by migration status.
    Guerrero EG; Villatoro JA; Kong Y; Fleiz C; Vega WA; Strathdee SA; Medina-Mora ME
    Subst Abuse Treat Prev Policy; 2014 Jul; 9():30. PubMed ID: 25074067
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Weekly patterns of drug treatment attendance.
    Svikis DS; Pickens RW; Schweitzer W; Johnson E; Haug N
    Am J Public Health; 1999 May; 89(5):752-5. PubMed ID: 10224989
    [TBL] [Abstract][Full Text] [Related]  

  • 87. A Multiple Indicators Multiple Causes (MIMIC) model of internal barriers to drug treatment in China.
    Qi C; Kelly BC; Liao Y; He H; Luo T; Deng H; Liu T; Hao W; Wang J
    Drug Alcohol Depend; 2015 Mar; 148():143-9. PubMed ID: 25640152
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Substance use disorder in individuals with mild intellectual disabilities; collaboration needed].
    Vandernagel JEL; van Duijvenbode N; van Horsen SWL
    Tijdschr Psychiatr; 2019; 61(11):798-803. PubMed ID: 31907891
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Addressing health disparities through promoting equity for individuals with intellectual disability.
    Ouellette-Kuntz H; Garcin N; Lewis ME; Minnes P; Martin C; Holden JJ
    Can J Public Health; 2005; 96 Suppl 2(Suppl 2):S8-22. PubMed ID: 16078552
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Gender disparities in the association between socio-demographics and non-communicable disease risk factors among adults with disabilities in Shanghai, China.
    Zhang Y; Chen G; Zhang Q; Lu J; Yu H
    PeerJ; 2018; 6():e4505. PubMed ID: 29576973
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Gender comparisons of drug abuse treatment outcomes and predictors.
    Hser YI; Huang D; Teruya C; Douglas Anglin M
    Drug Alcohol Depend; 2003 Dec; 72(3):255-64. PubMed ID: 14643942
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Clinical guidelines contribute to the health inequities experienced by individuals with intellectual disabilities.
    Mizen LA; Macfie ML; Findlay L; Cooper SA; Melville CA
    Implement Sci; 2012 May; 7():42. PubMed ID: 22578137
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Would People with Intellectual and Developmental Disabilities Benefit from Being Designated "Underserved"?
    Slashcheva L; Rader R; Sulkes S
    AMA J Ethics; 2016 Apr; 18(4):422-9. PubMed ID: 27099192
    [No Abstract]   [Full Text] [Related]  

  • 94. Issues in chemical dependency treatment and aftercare for people with learning differences.
    Campbell JA; Essex EL; Held G
    Health Soc Work; 1994 Feb; 19(1):63-70. PubMed ID: 8168781
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Gender differences in the perception of drug user treatment: assessing drug user treatment for youthful offenders.
    Hegamin A; Anglin G; Farabee D
    Subst Use Misuse; 2001 Dec; 36(14):2159-70. PubMed ID: 11794588
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Equity of access to healthcare for a patient with a severe intellectual disability.
    Anonymous
    BMJ Evid Based Med; 2024 May; 29(3):207-208. PubMed ID: 38360046
    [No Abstract]   [Full Text] [Related]  

  • 97. From generic to gender-responsive treatment: changes in social policies, treatment services, and outcomes of women in substance abuse treatment.
    Grella CE
    J Psychoactive Drugs; 2008 Nov; Suppl 5():327-43. PubMed ID: 19256044
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Intellectually disabled and addicted: a call for evidence based tailor-made interventions.
    Kiewik M; VanDerNagel JEL; Engels RCME; De Jong CAJ
    Addiction; 2017 Nov; 112(11):2067-2068. PubMed ID: 28868632
    [No Abstract]   [Full Text] [Related]  

  • 99. Assessing sex differences on treatment effectiveness from the drug abuse treatment outcome study (DATOS).
    Acharyya S; Zhang H
    Am J Drug Alcohol Abuse; 2003 May; 29(2):415-44. PubMed ID: 12765214
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Improving access to genetic testing for adults with intellectual disability: A literature review and lessons from a quality improvement project in East London.
    Adlington K; Smith J; Crabtree J; Win S; Rennie J; Khodatars K; Rosser E; Hall I
    Am J Med Genet B Neuropsychiatr Genet; 2019 Dec; 180(8):566-575. PubMed ID: 31077569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.